TYME Market Cap History
Below is a table of the TYME market cap history going back to 4/15/2015:

Date TYME Market Cap
4/15/2015593.45M
5/19/2015666.56M
8/10/2015726.81M
11/19/2015860.26M
3/23/2016744.70M
3/31/2016530.05M
4/30/2016963.73M
8/3/2016595.87M
10/31/2016306.87M
1/31/2017220.41M
5/26/2017250.15M
7/24/2017241.17M
7/31/2017379.70M
10/26/2017355.50M
2/5/2018382.70M
6/6/2018337.08M
7/26/2018313.80M
10/31/2018230.73M
2/7/2019275.92M
6/4/2019124.27M
8/2/2019124.27M
2/10/2016744.63M
10/29/2019152.25M
1/28/2020191.63M
5/18/2020209.63M
8/5/2020161.14M
11/6/2020121.06M
1/27/2021232.16M

Also see: TYME Shares Outstanding History
and TYME YTD Return
TYME Historical Market Cap:
-14.96% CAGR
TYME Historical Market Cap: +-14.96% CAGR

Mouse over chart for data details
4/15/2015 ...1/27/2021
Tyme Technologies is a biotechnology company developing cancer metabolism-based therapies (CMBTs™) that are intended to be effective across a range of solid tumors and hematologic cancers. Co.'s main clinical CMBT program, SM-88, is an oral investigational modified proprietary tyrosine derivative that is hypothesized to interrupt the metabolic processes of cancer cells by breaking down the cells' key defenses and leading to cell death through oxidative stress and exposure to the body's natural immune system. Co.'s TYME-18 is a CMBT compound under development that is delivered intratumorally. Like SM-88, TYME-18 utilizes the metabolism of cancer to create a treatment for inoperable tumors. We show 28 historical shares outstanding datapoints in our TYME shares outstanding history coverage, used to compute TYME market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TYME market cap history over the course of time is important for investors interested in comparing TYME's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TYME versus a peer is one thing; comparing TYME market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TYME can fluctuate over the course of history. With this page we aim to empower investors researching TYME by allowing them to research the TYME market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for TYME:
TYME SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Tyme Technologies (TYME) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

UHS Market Cap History
USPH Market Cap History
UTHR Market Cap History
UTMD Market Cap History
VAR Market Cap History
VBIV Market Cap History
VCEL Market Cap History
VCYT Market Cap History
VICL Market Cap History
VIV Market Cap History
More Healthcare companies »

 

TYME Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.